Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

DNA methylation profiling of circulatory monocytes in community-acquired pneumonia

ABSTRACT: In this study, we sought to broaden our understanding of circulatory monocyte functions captured during the acute (on hospital admission) and recovery (one-month follow-up) stages of patients diagnosed with community-acquired pneumonia (CAP).

ORGANISM(S): Homo sapiens

PROVIDER: GSE159474 | GEO | 2021/08/05

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Transcriptional profiling of circulatory monocytes in community-acquired pneumonia

Project description:In this study, we sought to broaden our understanding of circulatory monocyte functions captured during the acute (on hospital admission; day0) and recovery (one month follow-up) stages of patients diagnosed with community-acquired pneumonia (CAP).

2021-08-05 | GSE160329 | GEO

Whole blood gene expression profiles associated with mortality in community-acquired pneumonia

Project description:We aimed to examine the differences in the gene expression profile in peripheral blood at hospital admission between patients with community-acquired pneumonia (CAP) who died and survived during hospitalization. Whole blood samples for genome expression profile analysis were obtained within 24 hours of hospital admission. Gen set enrichment analysis (GSEA) identified gene sets positively enriched in the patients who survived, mainly related with interferon- alpha response, apoptosis, and sex hormones pathways. Similarly, GSEA identified gene sets positively enrichment for the patients who died (oxidative stress, endoplasmic reticulum stress, oxidative phosphorylation, and angiogenesis pathways).

2022-10-17 | GSE188309 | GEO

The circulatory small non-coding RNA landscape in health and sepsis due to community-acquired pneumonia

Project description:We here sought to firstly identify differentially abundant circulatory small non-coding RNA in critically ill patients with sepsis due to community-acquired pneumonia (CAP) patients as compared to healthy subjects, and secondly delineate those putatively targeted cellular pathways.

2021-08-18 | GSE137294 | GEO

Transcriptional profiling of circulatory monocytes in community-acquired pneumonia

Project description:Transcriptional profiling of circulatory monocytes in community-acquired pneumonia

| PRJNA672968 | ENA

DNA methylation profiling of circulatory monocytes in community-acquired pneumonia

Project description:DNA methylation profiling of circulatory monocytes in community-acquired pneumonia

| PRJNA669022 | ENA

Proteomic Profiling of Neutrophils and Plasma in Community-Acquired Pneumonia Reveals Crucial Proteins in Diverse Biological Pathways Linked to Clinical Outcome

Project description:Neutrophils are crucial first responders in respiratory infections and play a dichotomous role in the host response during community-acquired pneumonia (CAP): providing protection and potentially causing damage. Existing research on neutrophil function in CAP relies on animal or ex-vivo studies, leaving a gap in human-centered investigations. Addressing this, we used mass spectrometry to characterize the neutrophil proteome of CAP patients at general ward admission and related the proteome to controls and clinical outcomes. We included 57 CAP patients and 26 controls and quantified 3482 proteins in neutrophil lysates and 386 proteins in concurrently collected plasma. We found that the extensively studied granule-related proteins in non-human models did not drive the neutrophil proteome changes associated with CAP. Proteome alterations were primarily due to an increased abundance of proteins related to (aerobic) metabolic activity and (m)RNA translation/processing, concurrent with a diminished presence of cytoskeletal organization-related proteins (all pathways p<0.001). Higher and lower abundances of specific proteins, primarily constituents of these pathways, were associated with prolonged time to clinical stability in CAP. Moreover, we identified a pronounced presence of platelet-related proteins in neutrophil lysates of particularly viral CAP patients, suggesting the existence of neutrophil-platelet complexes in non-critically ill CAP patients. Of the measured proteins in neutrophils, 4.3% were also detected in plasma. Our findings offer novel insights into the neutrophil proteome in human CAP and might serve as a proteomic resource for forthcoming investigations. Additionally, our study could pave the way for targeted strategies to fine-tune neutrophil responses, potentially improving CAP patient management.

2024-10-01 | PXD048675 | Pride

Lipid metabolites as potential diagnostic and prognostic biomarkers for acute community acquired pneumonia

Project description:Early diagnosis of acute community-acquired pneumonia (CAP) is important in patient triage and treatment decisions. To identify biomarkers that distinguish patients with CAP from non-CAP controls, we conducted an untargeted global metabolome analysis for plasma samples from142 patients with CAP (CAP cases) and 97 without CAP (non-CAP controls). Thirteen lipid metabolites could discriminate between CAP cases and non-CAP controls with area-under-the-receiver-operating-characteristic curve of > 8 (P ≤ 10-9). The levels of glycosphingolipids, sphingomyelins, lysophosphatidylcholines and L-palmitoylcarnitine were higher, while the levels of lysophosphatidylethanolamines were lower in the CAP cases than those in non-CAP controls. All 13 metabolites could distinguish CAP cases from the non-infection, extrapulmonary infection and non-CAP respiratory tract infection subgroups. The levels of trihexosylceramide (d18:1/16:0) were higher, while the levels of lysophosphatidylethanolamines were lower, in the fatal than those of non-fatal CAP cases. Our ﬁndings suggest that lipid metabolites are potential diagnostic and prognostic biomarkers for CAP.

2016-08-11 | MTBLS354 | MetaboLights

Single-cell analysis identifies shared and distinct immune features of COVID-19, Influenza and other community-acquired pneumonia

Project description:The exact immunopathophysiology of COVID-19 remains clouded by methodological heterogeneity and a lack of relevant disease controls. The absence of single-cell investigations into the broader population of patients with community-acquired pneumonia (CAP) renders it difficult to distinguish immune features unique to COVID-19 from the common characteristics of a dysregulated host response to pneumonia. We performed integrated single-cell transcriptomic and proteomic analyses in PBMCs from a strictly matched cohort of eight patients with COVID-19, eight patients with CAP, and four non-infectious control subjects. With this balanced, multi-omic approach we describe diverging transcriptional and phenotypic patterns in T cell, NK cell and monocyte populations between patients with CAP caused by either SARS-CoV-2, Influenza A or other pathogens, and thereby expand our understanding of the peripheral immune response in different forms of CAP.

2021-08-31 | GSE164948 | GEO

Molecular Distance to Health Transcriptional Score and Disease Severity in Children Hospitalized with Community-Acquired Pneumonia

Project description:Community-acquired pneumonia (CAP) is a leading cause of hospitalization and mortality in children. Diagnosis remains challenging and there are no reliable tools to objectively classify patients according to disease severity or predict clinical outcomes. Molecular distance to health (MDTH) is a genomic score that measures the global perturbation of the transcriptional profile that may help classify patients by disease severity. We assessed the value of MDTH to assess disease severity in children hospitalized with CAP.

2018-12-26 | GSE103119 | GEO

The circulatory small non-coding RNA landscape in health and sepsis due to community-acquired pneumonia

Project description:The circulatory small non-coding RNA landscape in health and sepsis due to community-acquired pneumonia

| PRJNA565034 | ENA